Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
100.27
-0.40 (-0.40%)
At close: Nov 13, 2026, 4:00 PM EST
99.48
-0.79 (-0.79%)
After-hours: Nov 13, 2026, 7:56 PM EST
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of $11.43 billion as of November 13, 2026. It is the 1,934th most valuable company in the world and the 696th biggest in the United States. Its market cap has increased by 37.63% in one year.
Market Cap
11.43B
Enterprise Value
13.64B
1-Year Change
37.63%
Global Rank
Country Rank
#696 United States
Category
ChartMarket Cap Chart
Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $11.43B, an increase of 141,033.12%. That is a compound annual growth rate of 37.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 11.43B | 44.44% |
| Dec 31, 2025 | 7.91B | 30.11% |
| Dec 31, 2024 | 6.08B | 24.59% |
| Dec 29, 2023 | 4.88B | -36.54% |
| Dec 30, 2022 | 7.69B | 35.91% |
| Dec 31, 2021 | 5.66B | -1.95% |
| Dec 31, 2020 | 5.77B | 122.23% |
| Dec 31, 2019 | 2.60B | 22.85% |
| Dec 31, 2018 | 2.11B | -26.67% |
| Dec 29, 2017 | 2.88B | 125.43% |
| Dec 30, 2016 | 1.28B | -42.33% |
| Dec 31, 2015 | 2.22B | 83.35% |
| Dec 31, 2014 | 1.21B | -29.21% |
| Dec 31, 2013 | 1.71B | 126.01% |
| Dec 31, 2012 | 756.30M | -23.30% |
| Dec 30, 2011 | 986.10M | 23.98% |
| Dec 31, 2010 | 795.40M | 47.84% |
| Dec 31, 2009 | 538.00M | 17.96% |
| Dec 31, 2008 | 456.10M | -17.36% |
| Dec 31, 2007 | 551.90M | 6.38% |
| Dec 29, 2006 | 518.80M | 469.48% |
| Dec 30, 2005 | 91.10M | -13.07% |
| Dec 31, 2004 | 104.80M | 1,193.83% |
| Mar 16, 2004 | 8.10M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mentari Therapeutics | 11.72B |
| Summit Therapeutics | 11.44B |
| Bio-Techne | 11.44B |
| BioMarin Pharmaceutical | 11.06B |
| Kymera Therapeutics | 10.99B |
| Vaxcyte | 9.98B |
| Madrigal Pharmaceuticals | 9.83B |
| Spyre Therapeutics | 9.74B |